Article info

Download PDFPDF
Heart failure and cardiomyopathy
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
  1. Dr K M Goode, Department of Cardiology, Division of Cardiovascular & Respiratory Studies, Postgraduate Medical Institute, 1st Floor, Medical Research Building, Entrance 2, Castle Hill Hospital, Castle Road, Kingston-upon-Hull HU16 5JQ, UK; kevin.goode{at}hey.nhs.uk
View Full Text

Citation

Goode KM, John J, Rigby AS, et al
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

Publication history

  • Accepted January 20, 2009
  • First published February 19, 2009.
Online issue publication 
May 14, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.